Biomerica Inc. has released an investor presentation detailing its operations and strategic focus. The company highlights its expertise in developing and manufacturing advanced diagnostics for clinical labs, point-of-care, and at-home settings. Biomerica operates FDA, CE, and CFDA registered manufacturing facilities in California and Mexico, and collaborates with multinational pharmaceutical companies like Bio-Rad. The presentation underscores Biomerica's focus on transforming diagnostics into personalized therapies, particularly in gastrointestinal and chronic inflammatory diseases, leveraging a patented technology platform. The leadership team comprises experienced professionals with extensive backgrounds in scientific and medical fields. You can access the full presentation through the link below.